Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective cohort study

BACKGROUND: Pirfenidone is an antifibrotic agent that is potentially effective for the treatment of idiopathic pulmonary fibrosis (IPF). However, no study has reported on its prophylactic value against chemotherapy‐associated acute IPF exacerbations when combined with chemotherapy for non‐small cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yuji, Yano, Yukihiro, Kuge, Tomoki, Okabe, Fukuko, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yamaguchi, Toshihiko, Mori, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606001/
https://www.ncbi.nlm.nih.gov/pubmed/32986306
http://dx.doi.org/10.1111/1759-7714.13675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606001/
https://www.ncbi.nlm.nih.gov/pubmed/32986306
http://dx.doi.org/10.1111/1759-7714.13675

Ejemplares similares